ArticleCancer science2023

Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer.

Shuichi Mitsunaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.